Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses

類似資料

• Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control
  著者:: Salpini, Romina, 等
  出版事項: (2020)
• Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
  著者:: Mohammad Alkhatib, 等
  出版事項: (2022-04-01)
• HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
  著者:: Cento, Valeria, 等
  出版事項: (2012)
• Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside Inhibitors
  著者:: Ceccherini-Silberstein, Francesca, 等
  出版事項: (2007)
• New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts
  著者:: Svicher, Valentina, 等
  出版事項: (2019)